Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and emergence delirium in preschool children
ChiCTR2200066549Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Emergence agitation (EA) and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Emergence delirium. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200066549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066549.